Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
466 GBX | 0.00% | 0.00% | +27.67% |
Apr. 24 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
Apr. 23 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With a 2023 P/E ratio at 25.6 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's enterprise value to sales, at 4.73 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+27.67% | 157M | - | ||
-1.00% | 75.07B | B | ||
+21.68% | 23.56B | C+ | ||
+23.20% | 12.63B | C+ | ||
-1.22% | 8.17B | B- | ||
+25.27% | 7.49B | C+ | ||
-7.19% | 2.81B | C+ | ||
+17.91% | 2.31B | C | ||
-6.70% | 1.68B | C | ||
+94.13% | 1.4B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AQX Stock
- Ratings Aquis Exchange PLC